Navigation Links
Newer Versions of the Pill Pose No Added Risk to Gallbladder
Date:4/20/2011

WEDNESDAY, April 20 (HealthDay News) -- The risk of gallbladder disease is similar for women taking either newer or older types of birth control pills, a new study finds.

Recently, there have been concerns about a possible link between a fourth-generation progestin called drospirenone (marketed as Yaz or Yasmin in North America) and gallbladder disease, even though there are no published clinical studies on such an association.

Drospirenone is one of the most popular types of birth control pills in North America.

In this new study, researchers followed more than 2,700,000 women who used birth control pills containing ethinyl estradiol and a progestin continuously for at least six months.

There was no clinically significant difference in the risk of gallbladder disease among women taking different types of birth control pills, including those with drospirenone.

Reporting bias may be the reason for why gallbladder disease had seemed to be on the rise in women taking birth control pills with drospirenone, suggested Dr. Mahyar Etminan, of the Faculty of Medicine at University of British Columbia, and colleagues.

"The surge in the number of reported cases of gallbladder disease facilitated through the media may have contributed in making drospirenone appear to be associated with a higher risk of gallbladder disease compared with older contraceptives," the study authors wrote.

"However, the small effect sizes compounded with the possibility of residual biases in this observational study make it unlikely that these differences are clinically significant," they concluded.

The study, which was funded by a grant from the government of the Canadian province of Quebec and the McGill University Health Center, was published online April 18 in CMAJ (Canadian Medical Association Journal).

Birth control pills are used by an estimated 100 million women worldwide and are the most popular form of birth control.

More information

The American Congress of Obstetricians and Gynecologists has more about birth control pills.

-- Robert Preidt

SOURCE: CMAJ (Canadian Medical Association Journal), news release, April 19, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UCSF analysis shows newer surgery for neck pain may be better
2. Newer antimalarials more effective than quinine against severe malaria
3. Research shows rapid adoption of newer, more expensive prostate cancer treatments
4. Newer Drug May Help Prevent Fracture in Men With Prostate Cancer
5. Newer, more intense chemotherapy with less radiation not more effective against Hodgkins lymphoma
6. Decrease in suicide not linked to newer antidepressants
7. Newer Drugs Beat Gleevec in Head-to-Head Trials
8. In infant heart surgery, newer technique yields better survival in first year of life
9. Newer Genetic Info Adds Little to Predicting Breast Cancer
10. Newer Blood Thinner Beats Plavix for Bypass Patients
11. Newer Genetic Test for Autism More Effective
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Newer Versions of the Pill Pose No Added Risk to Gallbladder
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental functions, ... each and every seminar, session and class she offers. At the International ... which help energize creativity, focus mental functions, enhance athletic focus and skill sets, ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the ... the most widely used electronic patient signatures solution in healthcare . ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended ... all facets of clinical trial planning and management. Pharmica discussed the importance of ... In addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
(Date:2/17/2017)... ... 17, 2017 , ... Like most hospitals across the nation, Onslow Memorial Hospital ... the Hospital Readmission Reduction Program (HRRP), the return of a patient to the hospital ... the nation. While many providers are struggling to leverage limited resources and technology, Onslow ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, ... expected to grow at a CAGR of 9.4% from 2017-2022 and ... at a CAGR of 9.5% from 2017 to 2027. The market ... ... benefit you Read on to discover how you can exploit ...
(Date:2/17/2017)... 2017 Arvinas LLC, a private biotechnology company ... degradation, today announced the presentation of new preclinical data ... poster session at the American Society of Clinical Oncology ... Orlando, FL. "The new ... the potential of PROTACs to drive durable and robust ...
(Date:2/17/2017)... and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing ... ... the US, Canada , Japan , ... of World. Annual estimates and forecasts are provided for the period 2015 ... Market data and analytics are derived from primary and secondary research. ...
Breaking Medicine Technology: